Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating effectiveness of Indian teachers of psychiatry (IToP)-scholarship for teachers toward enrichment of psychiatry teaching skills (STEPS) training program among psychiatry teachers in India: A cross-sectional study.

Indian journal of psychiatry·2026
Same author

Cross-sectional observational study on prevalence and pattern of multimorbidity and its impact on geriatric outpatients in a south Indian tertiary hospital.

Frontiers in public health·2026
Same author

Factors Affecting Survival in Severe and Very Severe COPD after Admission in ICUs of Tertiary Care Centers of India (FAST COPD): Study Protocol for a Multicentric Cohort Study.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2024
Same author

Clinicoradiological findings in a case of cleidocranial dysplasia.

BMJ case reports·2024
Same author

Long COVID-19: A Systematic Review.

The Journal of the Association of Physicians of India·2024
Same author

Predictors of the utilisation of continuum of maternal health care services in India.

BMC health services research·2022

Related Experiment Video

Updated: May 31, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

HIV infection and thromboembolism.

H Basavanagowdappa1, M Suresh Babu, Subrahmanyam Karuturi

  • 1JSS Medical College, Mysore.

The Journal of the Association of Physicians of India
|July 15, 2011
PubMed
Summary

HIV patients have a higher risk of blood clots. This case highlights a patient with venous thromboembolism, normal CD4 count, and specific clotting factor deficiencies, suggesting a complex hypercoagulable state.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Immunology

Background:

  • Venous thromboembolism (VTE) is a known complication in Human Immunodeficiency Virus (HIV) infection.
  • HIV-associated thrombotic disease is often linked to various hemostatic abnormalities.
  • A hypercoagulable state can increase the risk of blood clots in affected individuals.

Observation:

  • This report details a case of a patient diagnosed with HIV and VTE.
  • The patient presented with a normal CD4+ T-cell count at the time of diagnosis.
  • Key laboratory findings included decreased levels of Protein C and Protein S, alongside elevated serum homocysteine.

Findings:

  • The observed coagulation profile suggests a specific prothrombotic state in this HIV patient.
  • Reduced Protein C and Protein S are critical inhibitors of coagulation, their deficiency predisposes to thrombosis.

More Related Videos

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

Related Experiment Videos

Last Updated: May 31, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

  • Increased homocysteine is an independent risk factor for VTE and may be exacerbated in HIV.
  • Implications:

    • This case underscores that VTE in HIV patients can occur even with preserved immune function (normal CD4 count).
    • It highlights the importance of investigating specific coagulation factor deficiencies and homocysteine levels in HIV-associated VTE.
    • Understanding these complex hemostatic derangements is crucial for effective VTE prevention and management in the HIV population.